HPV & Hepatitis Vaccines

  • HPV infection
  • Local infection at the mucosa
  • Attenuation of immune mechanism
  • Many viral subtypes
  • Viral entry occurs rapidly, but infected cell shows no inflammation
  • Virus elimination via natural cell clearance
  • Innate immune response, late induction of adaptive response (low antibody levels after long exposure to infection)
  • Natural immunity does not reliably prevent from infection
  • HBV infection
  • Systemic infection
  • Viral progression 1 to 6 months from infection to disease
  • Strong immune response
  • Neutralising antibodies and CTL activation
  • Immune mechanisms in subjects who recovered from HBV infection provide lifelong immunity

Related Conference of HPV & Hepatitis Vaccines

July 27-28, 2018

31st Annual Congress on Vaccines & Clinical Trials

Vancouver, Canada
Aug 27-29, 2018

Annual Congress and Expo on Vaccines & Immunology

Amsterdam, Netherlands
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan

HPV & Hepatitis Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in